Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-007669

Chief Financial Officer sold 3,326 shares at $11.11 ($36,954)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FRATES JAMES M Chief Financial Officer 2026-01-06 Sale −3,326 $11.11 $36,954 177,104 D: show line 1 in the form
Open-market sales · 3,326 sh · avg $11.11 · $36,954
Loading xslF345X05/ownership.xml…